Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-08 10:52 am Purchase |
2024-09-30 | 13G | MBX Biosciences, Inc. Common Stock MBX |
WELLINGTON MANAGEMENT CO LLP | 2,937,853 9.220% |
2,937,853 (New Position) |
Filing History |
| 2024-11-01 5:38 pm Purchase |
2024-09-30 | 13G | MBX Biosciences, Inc. Common Stock MBX |
Hawryluk P. Kent | 1,910,632 5.550% |
1,910,632 (New Position) |
Filing History |
| 2024-09-23 6:07 pm Purchase |
2024-09-16 | 13D | MBX Biosciences, Inc. Common Stock MBX |
Norwest Venture Partners XVI LP | 2,136,335 6.400% |
2,136,335 (New Position) |
Filing History |
| 2024-09-23 6:05 pm Purchase |
2024-09-16 | 13D | MBX Biosciences, Inc. Common Stock MBX |
New Enterprise Associates 17, L.P. | 3,614,486 11.400% |
3,614,486 (New Position) |
Filing History |
| 2024-09-23 4:34 pm Purchase |
2024-09-16 | 13D | MBX Biosciences, Inc. Common Stock MBX |
ORBIMED ADVISORS LLC | 3,812,215 12.000% |
3,812,215 (New Position) |
Filing History |
| 2024-09-23 4:00 pm Purchase |
2024-09-13 | 13G | MBX Biosciences, Inc. Common Stock MBX |
Deep Track Capital, LP | 3,018,935 9.480% |
3,018,935 (New Position) |
Filing History |
| 2024-09-23 10:48 am Purchase |
2024-09-16 | 13D | MBX Biosciences, Inc. Common Stock MBX |
Frazier Life Sciences Public Fund, L.P. | 5,985,347 18.800% |
5,985,347 (New Position) |
Filing History |
| 2024-09-20 10:13 am Purchase |
2024-09-13 | 13G | MBX Biosciences, Inc. Common Stock MBX |
Wellington Biomedical Innovation Master Investors (Cayman) II L.P. | 1,790,122 5.620% |
1,790,122 (New Position) |
Filing History |